Your browser doesn't support javascript.
loading
Coccidioidomycosis in Patients Treated With Ruxolitinib.
Kusne, Yael; Kimes, Kathryn E; Feller, Fionna F; Patron, Roberto; Banacloche, Juan Gea; Blair, Janis E; Vikram, Holenarasipur R; Ampel, Neil M.
Afiliación
  • Kusne Y; Department of Medicine, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
  • Kimes KE; Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
  • Feller FF; Department of Medicine, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
  • Patron R; Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
  • Banacloche JG; Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
  • Blair JE; Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
  • Vikram HR; Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
  • Ampel NM; Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
Open Forum Infect Dis ; 7(6): ofaa167, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32548203
ABSTRACT
We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos